Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health

Chao Pin Hsiao, Kristin Dickinson, Velda Gonzalez-Mercado, Debra Lynch Kelly, Nada Lukkahatai, Margaret McCabe, Samantha Mayo, Rita Musanti, Leorey N. Saligan

Research output: Contribution to journalArticle

Abstract

Purpose: This article aims to provide perspectives on the establishment of a consortium for nurse scientists with similar career trajectories interested in cancer-related symptoms (CRS) research. Hereby, we describe the development of and recent outcomes from the CRS consortium, the lessons learned in establishing the consortium, and future directions to advance the science of CRS. Model and Methods: New and innovative strategies are needed to address the complexity of CRS research. A CRS consortium was created to allow a mechanism for oncology nurse scientists with varying expertise to collaborate to advance CRS research. The National Institutes of Health (NIH) Symptom Science Model (SSM) guides the research of the CRS Consortium. Discussion and Conclusions: A need for improved CRS assessment and management has been identified. The CRS consortium was created as a collaborative think tank to begin to address this need. Guided by the NIH SSM, CRS consortium members have worked to define symptom phenotypes, enhance understanding of the biologic mechanisms that can contribute to symptom phenotypes, and develop tailored interventions to improve symptom management. Dissemination of the CRS consortium efforts involve publications and presentations. Clinical Implications: Nurse scientists interested in symptom science and biobehavorial research face many challenges on how to initiate and sustain independent programs of research. Through the formation of a CRS consortium, oncology nurse scientists can work together to address identified issues in symptom measurement and management.

Original languageEnglish (US)
JournalJournal of Nursing Scholarship
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Nurses
Health
Research
Neoplasms
National Institutes of Health (U.S.)
Phenotype
Symptom Assessment
Publications

Keywords

  • Cancer-related symptoms
  • consortium
  • symptom science

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Hsiao, C. P., Dickinson, K., Gonzalez-Mercado, V., Kelly, D. L., Lukkahatai, N., McCabe, M., ... Saligan, L. N. (Accepted/In press). Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health. Journal of Nursing Scholarship. https://doi.org/10.1111/jnu.12534

Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health. / Hsiao, Chao Pin; Dickinson, Kristin; Gonzalez-Mercado, Velda; Kelly, Debra Lynch; Lukkahatai, Nada; McCabe, Margaret; Mayo, Samantha; Musanti, Rita; Saligan, Leorey N.

In: Journal of Nursing Scholarship, 01.01.2019.

Research output: Contribution to journalArticle

Hsiao, Chao Pin ; Dickinson, Kristin ; Gonzalez-Mercado, Velda ; Kelly, Debra Lynch ; Lukkahatai, Nada ; McCabe, Margaret ; Mayo, Samantha ; Musanti, Rita ; Saligan, Leorey N. / Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health. In: Journal of Nursing Scholarship. 2019.
@article{76d0c4380d5d4097b43c3f0c4cac6797,
title = "Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health",
abstract = "Purpose: This article aims to provide perspectives on the establishment of a consortium for nurse scientists with similar career trajectories interested in cancer-related symptoms (CRS) research. Hereby, we describe the development of and recent outcomes from the CRS consortium, the lessons learned in establishing the consortium, and future directions to advance the science of CRS. Model and Methods: New and innovative strategies are needed to address the complexity of CRS research. A CRS consortium was created to allow a mechanism for oncology nurse scientists with varying expertise to collaborate to advance CRS research. The National Institutes of Health (NIH) Symptom Science Model (SSM) guides the research of the CRS Consortium. Discussion and Conclusions: A need for improved CRS assessment and management has been identified. The CRS consortium was created as a collaborative think tank to begin to address this need. Guided by the NIH SSM, CRS consortium members have worked to define symptom phenotypes, enhance understanding of the biologic mechanisms that can contribute to symptom phenotypes, and develop tailored interventions to improve symptom management. Dissemination of the CRS consortium efforts involve publications and presentations. Clinical Implications: Nurse scientists interested in symptom science and biobehavorial research face many challenges on how to initiate and sustain independent programs of research. Through the formation of a CRS consortium, oncology nurse scientists can work together to address identified issues in symptom measurement and management.",
keywords = "Cancer-related symptoms, consortium, symptom science",
author = "Hsiao, {Chao Pin} and Kristin Dickinson and Velda Gonzalez-Mercado and Kelly, {Debra Lynch} and Nada Lukkahatai and Margaret McCabe and Samantha Mayo and Rita Musanti and Saligan, {Leorey N.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/jnu.12534",
language = "English (US)",
journal = "Journal of Nursing Scholarship",
issn = "1527-6546",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health

AU - Hsiao, Chao Pin

AU - Dickinson, Kristin

AU - Gonzalez-Mercado, Velda

AU - Kelly, Debra Lynch

AU - Lukkahatai, Nada

AU - McCabe, Margaret

AU - Mayo, Samantha

AU - Musanti, Rita

AU - Saligan, Leorey N.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: This article aims to provide perspectives on the establishment of a consortium for nurse scientists with similar career trajectories interested in cancer-related symptoms (CRS) research. Hereby, we describe the development of and recent outcomes from the CRS consortium, the lessons learned in establishing the consortium, and future directions to advance the science of CRS. Model and Methods: New and innovative strategies are needed to address the complexity of CRS research. A CRS consortium was created to allow a mechanism for oncology nurse scientists with varying expertise to collaborate to advance CRS research. The National Institutes of Health (NIH) Symptom Science Model (SSM) guides the research of the CRS Consortium. Discussion and Conclusions: A need for improved CRS assessment and management has been identified. The CRS consortium was created as a collaborative think tank to begin to address this need. Guided by the NIH SSM, CRS consortium members have worked to define symptom phenotypes, enhance understanding of the biologic mechanisms that can contribute to symptom phenotypes, and develop tailored interventions to improve symptom management. Dissemination of the CRS consortium efforts involve publications and presentations. Clinical Implications: Nurse scientists interested in symptom science and biobehavorial research face many challenges on how to initiate and sustain independent programs of research. Through the formation of a CRS consortium, oncology nurse scientists can work together to address identified issues in symptom measurement and management.

AB - Purpose: This article aims to provide perspectives on the establishment of a consortium for nurse scientists with similar career trajectories interested in cancer-related symptoms (CRS) research. Hereby, we describe the development of and recent outcomes from the CRS consortium, the lessons learned in establishing the consortium, and future directions to advance the science of CRS. Model and Methods: New and innovative strategies are needed to address the complexity of CRS research. A CRS consortium was created to allow a mechanism for oncology nurse scientists with varying expertise to collaborate to advance CRS research. The National Institutes of Health (NIH) Symptom Science Model (SSM) guides the research of the CRS Consortium. Discussion and Conclusions: A need for improved CRS assessment and management has been identified. The CRS consortium was created as a collaborative think tank to begin to address this need. Guided by the NIH SSM, CRS consortium members have worked to define symptom phenotypes, enhance understanding of the biologic mechanisms that can contribute to symptom phenotypes, and develop tailored interventions to improve symptom management. Dissemination of the CRS consortium efforts involve publications and presentations. Clinical Implications: Nurse scientists interested in symptom science and biobehavorial research face many challenges on how to initiate and sustain independent programs of research. Through the formation of a CRS consortium, oncology nurse scientists can work together to address identified issues in symptom measurement and management.

KW - Cancer-related symptoms

KW - consortium

KW - symptom science

UR - http://www.scopus.com/inward/record.url?scp=85076268018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076268018&partnerID=8YFLogxK

U2 - 10.1111/jnu.12534

DO - 10.1111/jnu.12534

M3 - Article

C2 - 31804774

AN - SCOPUS:85076268018

JO - Journal of Nursing Scholarship

JF - Journal of Nursing Scholarship

SN - 1527-6546

ER -